GlassScriptPhysician profile
Jalu Patel
NPI 1447497532
$2,241.71
in general payments reported to CMS, 2019-2025
19 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $586 · 2021: $205 · 2022: $168 · 2023: $406 · 2024: $173 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $999.91 | 2019-2025 | 7 X 23mm Citrelock Implant, Pangea, Hoffmann |
| Orthofix Medical, INC. | $337.70 | 2019-2025 | Physio-Stim |
| Smith+Nephew, INC. | $311.59 | 2019-2025 | Collagenase Santyl, Regranex |
| Royal Biologics, INC. | $75.60 | 2019-2020 | |
| Allergan, INC. | $75.38 | 2019-2020 | |
| Organogenesis INC. | $66.51 | 2020-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $58.57 | 2022-2024 | Nuzyra |
| Kerecis Limited | $51.18 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biocomposites INC | $47.87 | 2025 | Stimulan |
| Tactile Systems Technology INC | $34.99 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Wright Medical Technology, INC. | $31.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.27 | 2019 | |
| Integra Lifesciences Corporation | $25.39 | 2019 | |
| Convatec INC. | $20.77 | 2024 | |
| Dynasplint Systems INC. | $18.56 | 2023 | Dynasplint |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $17.54 | 2019 | |
| Acera Surgical, INC. | $14.94 | 2019 | |
| Abbvie INC. | $14.42 | 2021 | |
| Polarityte, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jalu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.